Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia is linked to higher cardiovascular and metabolic risks, possibly due to irisin resistance.

Rats had lasting erectile problems after stopping a certain medication.

DMG-Na may improve blood flow and help hair growth without side effects.

AH-001 could be a safer and more effective treatment for hair loss.

Higher DHT levels are linked to worse heart changes in severe aortic valve stenosis patients.

ASA and CM may protect the brain and work better together.

Some men's prostate tissues have low enzyme levels due to genetic changes, possibly affecting treatment for prostate enlargement.

Men with severe hair loss may have a higher risk of heart disease.

Men with androgenetic alopecia do not have elevated DHEA-S levels.

5α-reductase inhibitors for hair loss can cause mild, reversible sexual side effects in some men.

Men with male pattern baldness don't necessarily have high levels of Dehydroepyandrosterone-sulfate, and there's no link between its levels and the severity of hair loss.

Alpha-blockers and 5-alpha reductase inhibitors don't significantly increase dementia risk.

5-α reductase inhibitors do not significantly affect male reproductive function but may reduce semen volume.

5α-reductase enzymes are crucial in certain disorders, and while treatment advances exist, more research on SRD5A3 is needed.

Men with hair loss don't necessarily have higher levels of the hormone DHEA-S, but this hormone tends to decrease with age.

The research found that androgens help control blood flow in the rat prostate through a specific binding site.

Long-term treatment with finasteride or combined therapy worsens sexual function in men with urinary issues.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

5-Alpha reductase inhibitors help treat enlarged prostate but may cause sexual side effects.

Men with better urinary symptoms have a lower risk of death.

Ranitidine and finasteride lower TMAO levels, reducing heart and kidney damage by changing gut bacteria.

5-alpha reductase inhibitors slightly reduce urinary symptoms and may lower surgery and acute retention risks in men.

Finasteride may help improve certain brain function issues linked to dopamine.

Dihydroartemisinin helps reduce prostate enlargement in rats by stopping the growth of prostate cells.